DOI: http://dx.doi.org/10.18203/2349-2902.isj20185488

Proteases and tissue repair: peri operative role of chymotrypsin: trypsin in surgical patients

Suhas Kondreddy, Shirin Palli

Abstract


Background: Proteolytic enzymes have been used to facilitate tissue repair ever since ancient times. Trypsin: Chymotrypsin, proteolytic enzyme oral preparation which has been in clinical use ever since 1960s, provides a better resolution of inflammatory symptoms and promotes speedier recovery of acute tissue injury by minimising the fibrinolytic shut down. This paper revisits the role and clinical utility of chymotrypsin: trypsin oral combination in tissue repair, in surgical patients. The aim of the present study was to determine the efficacy of chymotrypsin n trypsin in reducing post-operative oedema and haematoma formation and its role in surgical prophylaxis and scar formation.

Methods: A prospective study was done on 50 electively posted surgical patients during a period of 6months comparing placebo with chymotrypsin and trypsin oral combination.

Results: Statistically significant reduction in post-operative oedema, seroma and haematoma formation and reduction in pain and incidence of suture site infection, better cosmetic appearance of the scar and decline in need for secondary suturing was noted.

Conclusions: From the current study, it is thus concluded that trypsin: chymotrypsin prophylaxis pre-operatively and post-operative treatment in surgical patients hastens the healing process and significantly reduces the recovery time.


Keywords


Chymoral forte, Chymotrypsin: trypsin, Proteases

Full Text:

PDF

References


Henderson R. Catalytic activity of α-chymotrypsin in which histidine-57 has been methylated. Biochem J. 1971;124(1):13-18.

Xue M, Jackson CJ. Extracellular matrix reorganization during wound healing and its impact on abnormal scarring. Adv Wound Care. 2015;4(3):119-36.

Latha B, Ramakrishnan KM, Jayaraman V, Babu M. Action of trypsin: chymotrypsin (Chymoral forte DS) preparation on acute-phase proteins following burn injury in humans. Burns. 1997 Mar 1;23:S3-7.

McCarty SM, Percival SL. Proteases and delayed wound healing. Adv Wound Care. 2013;2(8):438-47.

Bogner RL, Snyder CC. High dosage oral chymotrypsin as an adjunct in plastic surgery. J Int Coll Surgeons. 1962 Mar;37:289-95.

Singh N, Bhattacharyya D. Proteases in wound healing and immunity. In: Chakraborti S, Chakraborti T, Dhalla NS, editors. Proteases in human diseases. Singapore: Springer; 2017:147-170.

Shaw PC. The use of a trypsin-chymotrypsin formulation in fractures of the hand. Br J Clin Pract. 1969 Jan 1;23(1):25.

Tsomides J, Goldberg RI. Controlled evaluation of oral chymotrypsin-trypsin treatment of injuries to head and face. Clin Med. 1969 Jan 1;76(11):40.

Sulniute R, Shen Y, Guo YZ, Fallah M, Ahlskog N, Ny L, et al. Plasminogen is a critical regulator of cutaneous wound healing. Thrombosis Haemostasis. 2016 May;115(05):1001-9.

Ambrus JL, Lassman HB, De Marchi JJ. Absorption of exogenous and endogenousproteolytic enzymes. Clin Pharmacol Therapeut. 1967 May 1;8(3):362-8.

Bruni M, Quarti GT, Baresi A, Bellinzoni G. A follow-up of the protein pattern after operations in patients treated with an oral enzyme. Arzneimittel-Forschung. 1980;30(11):1922-5.

Apsangikar P, Naik M, Tike C. Analysis of an open multicentric study of the efficacy, safety and tolerability of Chymoral Forte in resolving signs and symptoms of inflammation in patients with traumatic injuries. Hospital Today. 2005;10(1).

Werner M, Cohen G. Changes in serum proteins in the immediate post-operative period. Clin Sci. 1969;36:173-84.

Glenn EM, Bowman BJ, Koslowske TC. In:Chemical Biology of Inflammation. New York; Pergamon Press, 1968.